Global Pemetrexed Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.
LPI (LP Information)' newest research report, the “Pemetrexed Industry Forecast” looks at past sales and reviews total world Pemetrexed sales in 2022, providing a comprehensive analysis by region and market sector of projected Pemetrexed sales for 2023 through 2029. With Pemetrexed sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pemetrexed industry.
This Insight Report provides a comprehensive analysis of the global Pemetrexed landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pemetrexed portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pemetrexed market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pemetrexed and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pemetrexed.
The global Pemetrexed market size is projected to grow from US$ 1685.7 million in 2022 to US$ 1773.3 million in 2029; it is expected to grow at a CAGR of 1773.3 from 2023 to 2029.
United States market for Pemetrexed is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pemetrexed is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pemetrexed is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pemetrexed players cover Eli Lilly, Abbott Laboratories, Cadila Healthcare, Eagle Pharmaceuticals and Stada Arzneimittel, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pemetrexed market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pemetrexed market?
What factors are driving Pemetrexed market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pemetrexed market opportunities vary by end market size?
How does Pemetrexed break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.
LPI (LP Information)' newest research report, the “Pemetrexed Industry Forecast” looks at past sales and reviews total world Pemetrexed sales in 2022, providing a comprehensive analysis by region and market sector of projected Pemetrexed sales for 2023 through 2029. With Pemetrexed sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pemetrexed industry.
This Insight Report provides a comprehensive analysis of the global Pemetrexed landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pemetrexed portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pemetrexed market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pemetrexed and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pemetrexed.
The global Pemetrexed market size is projected to grow from US$ 1685.7 million in 2022 to US$ 1773.3 million in 2029; it is expected to grow at a CAGR of 1773.3 from 2023 to 2029.
United States market for Pemetrexed is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pemetrexed is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pemetrexed is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pemetrexed players cover Eli Lilly, Abbott Laboratories, Cadila Healthcare, Eagle Pharmaceuticals and Stada Arzneimittel, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pemetrexed market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 100mg
- 500mg
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly
- Abbott Laboratories
- Cadila Healthcare
- Eagle Pharmaceuticals
- Stada Arzneimittel
What is the 10-year outlook for the global Pemetrexed market?
What factors are driving Pemetrexed market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pemetrexed market opportunities vary by end market size?
How does Pemetrexed break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pemetrexed Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pemetrexed by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pemetrexed by Country/Region, 2018, 2022 & 2029
2.2 Pemetrexed Segment by Type
2.2.1 100mg
2.2.2 500mg
2.3 Pemetrexed Sales by Type
2.3.1 Global Pemetrexed Sales Market Share by Type (2018-2023)
2.3.2 Global Pemetrexed Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pemetrexed Sale Price by Type (2018-2023)
2.4 Pemetrexed Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Pemetrexed Sales by Application
2.5.1 Global Pemetrexed Sale Market Share by Application (2018-2023)
2.5.2 Global Pemetrexed Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pemetrexed Sale Price by Application (2018-2023)
3 GLOBAL PEMETREXED BY COMPANY
3.1 Global Pemetrexed Breakdown Data by Company
3.1.1 Global Pemetrexed Annual Sales by Company (2018-2023)
3.1.2 Global Pemetrexed Sales Market Share by Company (2018-2023)
3.2 Global Pemetrexed Annual Revenue by Company (2018-2023)
3.2.1 Global Pemetrexed Revenue by Company (2018-2023)
3.2.2 Global Pemetrexed Revenue Market Share by Company (2018-2023)
3.3 Global Pemetrexed Sale Price by Company
3.4 Key Manufacturers Pemetrexed Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pemetrexed Product Location Distribution
3.4.2 Players Pemetrexed Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PEMETREXED BY GEOGRAPHIC REGION
4.1 World Historic Pemetrexed Market Size by Geographic Region (2018-2023)
4.1.1 Global Pemetrexed Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pemetrexed Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pemetrexed Market Size by Country/Region (2018-2023)
4.2.1 Global Pemetrexed Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pemetrexed Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pemetrexed Sales Growth
4.4 APAC Pemetrexed Sales Growth
4.5 Europe Pemetrexed Sales Growth
4.6 Middle East & Africa Pemetrexed Sales Growth
5 AMERICAS
5.1 Americas Pemetrexed Sales by Country
5.1.1 Americas Pemetrexed Sales by Country (2018-2023)
5.1.2 Americas Pemetrexed Revenue by Country (2018-2023)
5.2 Americas Pemetrexed Sales by Type
5.3 Americas Pemetrexed Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pemetrexed Sales by Region
6.1.1 APAC Pemetrexed Sales by Region (2018-2023)
6.1.2 APAC Pemetrexed Revenue by Region (2018-2023)
6.2 APAC Pemetrexed Sales by Type
6.3 APAC Pemetrexed Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pemetrexed by Country
7.1.1 Europe Pemetrexed Sales by Country (2018-2023)
7.1.2 Europe Pemetrexed Revenue by Country (2018-2023)
7.2 Europe Pemetrexed Sales by Type
7.3 Europe Pemetrexed Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pemetrexed by Country
8.1.1 Middle East & Africa Pemetrexed Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pemetrexed Revenue by Country (2018-2023)
8.2 Middle East & Africa Pemetrexed Sales by Type
8.3 Middle East & Africa Pemetrexed Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pemetrexed
10.3 Manufacturing Process Analysis of Pemetrexed
10.4 Industry Chain Structure of Pemetrexed
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pemetrexed Distributors
11.3 Pemetrexed Customer
12 WORLD FORECAST REVIEW FOR PEMETREXED BY GEOGRAPHIC REGION
12.1 Global Pemetrexed Market Size Forecast by Region
12.1.1 Global Pemetrexed Forecast by Region (2024-2029)
12.1.2 Global Pemetrexed Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pemetrexed Forecast by Type
12.7 Global Pemetrexed Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Pemetrexed Product Portfolios and Specifications
13.1.3 Eli Lilly Pemetrexed Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Pemetrexed Product Portfolios and Specifications
13.2.3 Abbott Laboratories Pemetrexed Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Cadila Healthcare
13.3.1 Cadila Healthcare Company Information
13.3.2 Cadila Healthcare Pemetrexed Product Portfolios and Specifications
13.3.3 Cadila Healthcare Pemetrexed Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Cadila Healthcare Main Business Overview
13.3.5 Cadila Healthcare Latest Developments
13.4 Eagle Pharmaceuticals
13.4.1 Eagle Pharmaceuticals Company Information
13.4.2 Eagle Pharmaceuticals Pemetrexed Product Portfolios and Specifications
13.4.3 Eagle Pharmaceuticals Pemetrexed Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Eagle Pharmaceuticals Main Business Overview
13.4.5 Eagle Pharmaceuticals Latest Developments
13.5 Stada Arzneimittel
13.5.1 Stada Arzneimittel Company Information
13.5.2 Stada Arzneimittel Pemetrexed Product Portfolios and Specifications
13.5.3 Stada Arzneimittel Pemetrexed Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Stada Arzneimittel Main Business Overview
13.5.5 Stada Arzneimittel Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pemetrexed Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pemetrexed by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pemetrexed by Country/Region, 2018, 2022 & 2029
2.2 Pemetrexed Segment by Type
2.2.1 100mg
2.2.2 500mg
2.3 Pemetrexed Sales by Type
2.3.1 Global Pemetrexed Sales Market Share by Type (2018-2023)
2.3.2 Global Pemetrexed Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pemetrexed Sale Price by Type (2018-2023)
2.4 Pemetrexed Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Pemetrexed Sales by Application
2.5.1 Global Pemetrexed Sale Market Share by Application (2018-2023)
2.5.2 Global Pemetrexed Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pemetrexed Sale Price by Application (2018-2023)
3 GLOBAL PEMETREXED BY COMPANY
3.1 Global Pemetrexed Breakdown Data by Company
3.1.1 Global Pemetrexed Annual Sales by Company (2018-2023)
3.1.2 Global Pemetrexed Sales Market Share by Company (2018-2023)
3.2 Global Pemetrexed Annual Revenue by Company (2018-2023)
3.2.1 Global Pemetrexed Revenue by Company (2018-2023)
3.2.2 Global Pemetrexed Revenue Market Share by Company (2018-2023)
3.3 Global Pemetrexed Sale Price by Company
3.4 Key Manufacturers Pemetrexed Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pemetrexed Product Location Distribution
3.4.2 Players Pemetrexed Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PEMETREXED BY GEOGRAPHIC REGION
4.1 World Historic Pemetrexed Market Size by Geographic Region (2018-2023)
4.1.1 Global Pemetrexed Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pemetrexed Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pemetrexed Market Size by Country/Region (2018-2023)
4.2.1 Global Pemetrexed Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pemetrexed Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pemetrexed Sales Growth
4.4 APAC Pemetrexed Sales Growth
4.5 Europe Pemetrexed Sales Growth
4.6 Middle East & Africa Pemetrexed Sales Growth
5 AMERICAS
5.1 Americas Pemetrexed Sales by Country
5.1.1 Americas Pemetrexed Sales by Country (2018-2023)
5.1.2 Americas Pemetrexed Revenue by Country (2018-2023)
5.2 Americas Pemetrexed Sales by Type
5.3 Americas Pemetrexed Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pemetrexed Sales by Region
6.1.1 APAC Pemetrexed Sales by Region (2018-2023)
6.1.2 APAC Pemetrexed Revenue by Region (2018-2023)
6.2 APAC Pemetrexed Sales by Type
6.3 APAC Pemetrexed Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pemetrexed by Country
7.1.1 Europe Pemetrexed Sales by Country (2018-2023)
7.1.2 Europe Pemetrexed Revenue by Country (2018-2023)
7.2 Europe Pemetrexed Sales by Type
7.3 Europe Pemetrexed Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pemetrexed by Country
8.1.1 Middle East & Africa Pemetrexed Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pemetrexed Revenue by Country (2018-2023)
8.2 Middle East & Africa Pemetrexed Sales by Type
8.3 Middle East & Africa Pemetrexed Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pemetrexed
10.3 Manufacturing Process Analysis of Pemetrexed
10.4 Industry Chain Structure of Pemetrexed
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pemetrexed Distributors
11.3 Pemetrexed Customer
12 WORLD FORECAST REVIEW FOR PEMETREXED BY GEOGRAPHIC REGION
12.1 Global Pemetrexed Market Size Forecast by Region
12.1.1 Global Pemetrexed Forecast by Region (2024-2029)
12.1.2 Global Pemetrexed Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pemetrexed Forecast by Type
12.7 Global Pemetrexed Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Pemetrexed Product Portfolios and Specifications
13.1.3 Eli Lilly Pemetrexed Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Pemetrexed Product Portfolios and Specifications
13.2.3 Abbott Laboratories Pemetrexed Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Cadila Healthcare
13.3.1 Cadila Healthcare Company Information
13.3.2 Cadila Healthcare Pemetrexed Product Portfolios and Specifications
13.3.3 Cadila Healthcare Pemetrexed Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Cadila Healthcare Main Business Overview
13.3.5 Cadila Healthcare Latest Developments
13.4 Eagle Pharmaceuticals
13.4.1 Eagle Pharmaceuticals Company Information
13.4.2 Eagle Pharmaceuticals Pemetrexed Product Portfolios and Specifications
13.4.3 Eagle Pharmaceuticals Pemetrexed Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Eagle Pharmaceuticals Main Business Overview
13.4.5 Eagle Pharmaceuticals Latest Developments
13.5 Stada Arzneimittel
13.5.1 Stada Arzneimittel Company Information
13.5.2 Stada Arzneimittel Pemetrexed Product Portfolios and Specifications
13.5.3 Stada Arzneimittel Pemetrexed Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Stada Arzneimittel Main Business Overview
13.5.5 Stada Arzneimittel Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pemetrexed Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pemetrexed Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 100mg
Table 4. Major Players of 500mg
Table 5. Global Pemetrexed Sales by Type (2018-2023) & (Units)
Table 6. Global Pemetrexed Sales Market Share by Type (2018-2023)
Table 7. Global Pemetrexed Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pemetrexed Revenue Market Share by Type (2018-2023)
Table 9. Global Pemetrexed Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Pemetrexed Sales by Application (2018-2023) & (Units)
Table 11. Global Pemetrexed Sales Market Share by Application (2018-2023)
Table 12. Global Pemetrexed Revenue by Application (2018-2023)
Table 13. Global Pemetrexed Revenue Market Share by Application (2018-2023)
Table 14. Global Pemetrexed Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Pemetrexed Sales by Company (2018-2023) & (Units)
Table 16. Global Pemetrexed Sales Market Share by Company (2018-2023)
Table 17. Global Pemetrexed Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pemetrexed Revenue Market Share by Company (2018-2023)
Table 19. Global Pemetrexed Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Pemetrexed Producing Area Distribution and Sales Area
Table 21. Players Pemetrexed Products Offered
Table 22. Pemetrexed Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pemetrexed Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Pemetrexed Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pemetrexed Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pemetrexed Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pemetrexed Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Pemetrexed Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pemetrexed Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pemetrexed Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pemetrexed Sales by Country (2018-2023) & (Units)
Table 34. Americas Pemetrexed Sales Market Share by Country (2018-2023)
Table 35. Americas Pemetrexed Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pemetrexed Revenue Market Share by Country (2018-2023)
Table 37. Americas Pemetrexed Sales by Type (2018-2023) & (Units)
Table 38. Americas Pemetrexed Sales by Application (2018-2023) & (Units)
Table 39. APAC Pemetrexed Sales by Region (2018-2023) & (Units)
Table 40. APAC Pemetrexed Sales Market Share by Region (2018-2023)
Table 41. APAC Pemetrexed Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pemetrexed Revenue Market Share by Region (2018-2023)
Table 43. APAC Pemetrexed Sales by Type (2018-2023) & (Units)
Table 44. APAC Pemetrexed Sales by Application (2018-2023) & (Units)
Table 45. Europe Pemetrexed Sales by Country (2018-2023) & (Units)
Table 46. Europe Pemetrexed Sales Market Share by Country (2018-2023)
Table 47. Europe Pemetrexed Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pemetrexed Revenue Market Share by Country (2018-2023)
Table 49. Europe Pemetrexed Sales by Type (2018-2023) & (Units)
Table 50. Europe Pemetrexed Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Pemetrexed Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Pemetrexed Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pemetrexed Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pemetrexed Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pemetrexed Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Pemetrexed Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Pemetrexed
Table 58. Key Market Challenges & Risks of Pemetrexed
Table 59. Key Industry Trends of Pemetrexed
Table 60. Pemetrexed Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pemetrexed Distributors List
Table 63. Pemetrexed Customer List
Table 64. Global Pemetrexed Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Pemetrexed Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pemetrexed Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Pemetrexed Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pemetrexed Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Pemetrexed Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pemetrexed Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Pemetrexed Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pemetrexed Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Pemetrexed Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pemetrexed Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Pemetrexed Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pemetrexed Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Pemetrexed Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Eli Lilly Basic Information, Pemetrexed Manufacturing Base, Sales Area and Its Competitors
Table 79. Eli Lilly Pemetrexed Product Portfolios and Specifications
Table 80. Eli Lilly Pemetrexed Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Eli Lilly Main Business
Table 82. Eli Lilly Latest Developments
Table 83. Abbott Laboratories Basic Information, Pemetrexed Manufacturing Base, Sales Area and Its Competitors
Table 84. Abbott Laboratories Pemetrexed Product Portfolios and Specifications
Table 85. Abbott Laboratories Pemetrexed Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Abbott Laboratories Main Business
Table 87. Abbott Laboratories Latest Developments
Table 88. Cadila Healthcare Basic Information, Pemetrexed Manufacturing Base, Sales Area and Its Competitors
Table 89. Cadila Healthcare Pemetrexed Product Portfolios and Specifications
Table 90. Cadila Healthcare Pemetrexed Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Cadila Healthcare Main Business
Table 92. Cadila Healthcare Latest Developments
Table 93. Eagle Pharmaceuticals Basic Information, Pemetrexed Manufacturing Base, Sales Area and Its Competitors
Table 94. Eagle Pharmaceuticals Pemetrexed Product Portfolios and Specifications
Table 95. Eagle Pharmaceuticals Pemetrexed Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Eagle Pharmaceuticals Main Business
Table 97. Eagle Pharmaceuticals Latest Developments
Table 98. Stada Arzneimittel Basic Information, Pemetrexed Manufacturing Base, Sales Area and Its Competitors
Table 99. Stada Arzneimittel Pemetrexed Product Portfolios and Specifications
Table 100. Stada Arzneimittel Pemetrexed Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Stada Arzneimittel Main Business
Table 102. Stada Arzneimittel Latest Developments
Table 1. Pemetrexed Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pemetrexed Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 100mg
Table 4. Major Players of 500mg
Table 5. Global Pemetrexed Sales by Type (2018-2023) & (Units)
Table 6. Global Pemetrexed Sales Market Share by Type (2018-2023)
Table 7. Global Pemetrexed Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pemetrexed Revenue Market Share by Type (2018-2023)
Table 9. Global Pemetrexed Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Pemetrexed Sales by Application (2018-2023) & (Units)
Table 11. Global Pemetrexed Sales Market Share by Application (2018-2023)
Table 12. Global Pemetrexed Revenue by Application (2018-2023)
Table 13. Global Pemetrexed Revenue Market Share by Application (2018-2023)
Table 14. Global Pemetrexed Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Pemetrexed Sales by Company (2018-2023) & (Units)
Table 16. Global Pemetrexed Sales Market Share by Company (2018-2023)
Table 17. Global Pemetrexed Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pemetrexed Revenue Market Share by Company (2018-2023)
Table 19. Global Pemetrexed Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Pemetrexed Producing Area Distribution and Sales Area
Table 21. Players Pemetrexed Products Offered
Table 22. Pemetrexed Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pemetrexed Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Pemetrexed Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pemetrexed Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pemetrexed Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pemetrexed Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Pemetrexed Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pemetrexed Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pemetrexed Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pemetrexed Sales by Country (2018-2023) & (Units)
Table 34. Americas Pemetrexed Sales Market Share by Country (2018-2023)
Table 35. Americas Pemetrexed Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pemetrexed Revenue Market Share by Country (2018-2023)
Table 37. Americas Pemetrexed Sales by Type (2018-2023) & (Units)
Table 38. Americas Pemetrexed Sales by Application (2018-2023) & (Units)
Table 39. APAC Pemetrexed Sales by Region (2018-2023) & (Units)
Table 40. APAC Pemetrexed Sales Market Share by Region (2018-2023)
Table 41. APAC Pemetrexed Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pemetrexed Revenue Market Share by Region (2018-2023)
Table 43. APAC Pemetrexed Sales by Type (2018-2023) & (Units)
Table 44. APAC Pemetrexed Sales by Application (2018-2023) & (Units)
Table 45. Europe Pemetrexed Sales by Country (2018-2023) & (Units)
Table 46. Europe Pemetrexed Sales Market Share by Country (2018-2023)
Table 47. Europe Pemetrexed Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pemetrexed Revenue Market Share by Country (2018-2023)
Table 49. Europe Pemetrexed Sales by Type (2018-2023) & (Units)
Table 50. Europe Pemetrexed Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Pemetrexed Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Pemetrexed Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pemetrexed Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pemetrexed Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pemetrexed Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Pemetrexed Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Pemetrexed
Table 58. Key Market Challenges & Risks of Pemetrexed
Table 59. Key Industry Trends of Pemetrexed
Table 60. Pemetrexed Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pemetrexed Distributors List
Table 63. Pemetrexed Customer List
Table 64. Global Pemetrexed Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Pemetrexed Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pemetrexed Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Pemetrexed Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pemetrexed Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Pemetrexed Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pemetrexed Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Pemetrexed Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pemetrexed Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Pemetrexed Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pemetrexed Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Pemetrexed Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pemetrexed Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Pemetrexed Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Eli Lilly Basic Information, Pemetrexed Manufacturing Base, Sales Area and Its Competitors
Table 79. Eli Lilly Pemetrexed Product Portfolios and Specifications
Table 80. Eli Lilly Pemetrexed Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Eli Lilly Main Business
Table 82. Eli Lilly Latest Developments
Table 83. Abbott Laboratories Basic Information, Pemetrexed Manufacturing Base, Sales Area and Its Competitors
Table 84. Abbott Laboratories Pemetrexed Product Portfolios and Specifications
Table 85. Abbott Laboratories Pemetrexed Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Abbott Laboratories Main Business
Table 87. Abbott Laboratories Latest Developments
Table 88. Cadila Healthcare Basic Information, Pemetrexed Manufacturing Base, Sales Area and Its Competitors
Table 89. Cadila Healthcare Pemetrexed Product Portfolios and Specifications
Table 90. Cadila Healthcare Pemetrexed Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Cadila Healthcare Main Business
Table 92. Cadila Healthcare Latest Developments
Table 93. Eagle Pharmaceuticals Basic Information, Pemetrexed Manufacturing Base, Sales Area and Its Competitors
Table 94. Eagle Pharmaceuticals Pemetrexed Product Portfolios and Specifications
Table 95. Eagle Pharmaceuticals Pemetrexed Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Eagle Pharmaceuticals Main Business
Table 97. Eagle Pharmaceuticals Latest Developments
Table 98. Stada Arzneimittel Basic Information, Pemetrexed Manufacturing Base, Sales Area and Its Competitors
Table 99. Stada Arzneimittel Pemetrexed Product Portfolios and Specifications
Table 100. Stada Arzneimittel Pemetrexed Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Stada Arzneimittel Main Business
Table 102. Stada Arzneimittel Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pemetrexed
Figure 2. Pemetrexed Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pemetrexed Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Pemetrexed Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pemetrexed Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 100mg
Figure 10. Product Picture of 500mg
Figure 11. Global Pemetrexed Sales Market Share by Type in 2022
Figure 12. Global Pemetrexed Revenue Market Share by Type (2018-2023)
Figure 13. Pemetrexed Consumed in Hospital Pharmacies
Figure 14. Global Pemetrexed Market: Hospital Pharmacies (2018-2023) & (Units)
Figure 15. Pemetrexed Consumed in Retail Pharmacies
Figure 16. Global Pemetrexed Market: Retail Pharmacies (2018-2023) & (Units)
Figure 17. Pemetrexed Consumed in Online Pharmacies
Figure 18. Global Pemetrexed Market: Online Pharmacies (2018-2023) & (Units)
Figure 19. Global Pemetrexed Sales Market Share by Application (2022)
Figure 20. Global Pemetrexed Revenue Market Share by Application in 2022
Figure 21. Pemetrexed Sales Market by Company in 2022 (Units)
Figure 22. Global Pemetrexed Sales Market Share by Company in 2022
Figure 23. Pemetrexed Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Pemetrexed Revenue Market Share by Company in 2022
Figure 25. Global Pemetrexed Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Pemetrexed Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Pemetrexed Sales 2018-2023 (Units)
Figure 28. Americas Pemetrexed Revenue 2018-2023 ($ Millions)
Figure 29. APAC Pemetrexed Sales 2018-2023 (Units)
Figure 30. APAC Pemetrexed Revenue 2018-2023 ($ Millions)
Figure 31. Europe Pemetrexed Sales 2018-2023 (Units)
Figure 32. Europe Pemetrexed Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Pemetrexed Sales 2018-2023 (Units)
Figure 34. Middle East & Africa Pemetrexed Revenue 2018-2023 ($ Millions)
Figure 35. Americas Pemetrexed Sales Market Share by Country in 2022
Figure 36. Americas Pemetrexed Revenue Market Share by Country in 2022
Figure 37. Americas Pemetrexed Sales Market Share by Type (2018-2023)
Figure 38. Americas Pemetrexed Sales Market Share by Application (2018-2023)
Figure 39. United States Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Pemetrexed Sales Market Share by Region in 2022
Figure 44. APAC Pemetrexed Revenue Market Share by Regions in 2022
Figure 45. APAC Pemetrexed Sales Market Share by Type (2018-2023)
Figure 46. APAC Pemetrexed Sales Market Share by Application (2018-2023)
Figure 47. China Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Pemetrexed Sales Market Share by Country in 2022
Figure 55. Europe Pemetrexed Revenue Market Share by Country in 2022
Figure 56. Europe Pemetrexed Sales Market Share by Type (2018-2023)
Figure 57. Europe Pemetrexed Sales Market Share by Application (2018-2023)
Figure 58. Germany Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Pemetrexed Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Pemetrexed Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Pemetrexed Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Pemetrexed Sales Market Share by Application (2018-2023)
Figure 67. Egypt Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Pemetrexed in 2022
Figure 73. Manufacturing Process Analysis of Pemetrexed
Figure 74. Industry Chain Structure of Pemetrexed
Figure 75. Channels of Distribution
Figure 76. Global Pemetrexed Sales Market Forecast by Region (2024-2029)
Figure 77. Global Pemetrexed Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Pemetrexed Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Pemetrexed Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Pemetrexed Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Pemetrexed Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pemetrexed
Figure 2. Pemetrexed Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pemetrexed Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Pemetrexed Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pemetrexed Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 100mg
Figure 10. Product Picture of 500mg
Figure 11. Global Pemetrexed Sales Market Share by Type in 2022
Figure 12. Global Pemetrexed Revenue Market Share by Type (2018-2023)
Figure 13. Pemetrexed Consumed in Hospital Pharmacies
Figure 14. Global Pemetrexed Market: Hospital Pharmacies (2018-2023) & (Units)
Figure 15. Pemetrexed Consumed in Retail Pharmacies
Figure 16. Global Pemetrexed Market: Retail Pharmacies (2018-2023) & (Units)
Figure 17. Pemetrexed Consumed in Online Pharmacies
Figure 18. Global Pemetrexed Market: Online Pharmacies (2018-2023) & (Units)
Figure 19. Global Pemetrexed Sales Market Share by Application (2022)
Figure 20. Global Pemetrexed Revenue Market Share by Application in 2022
Figure 21. Pemetrexed Sales Market by Company in 2022 (Units)
Figure 22. Global Pemetrexed Sales Market Share by Company in 2022
Figure 23. Pemetrexed Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Pemetrexed Revenue Market Share by Company in 2022
Figure 25. Global Pemetrexed Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Pemetrexed Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Pemetrexed Sales 2018-2023 (Units)
Figure 28. Americas Pemetrexed Revenue 2018-2023 ($ Millions)
Figure 29. APAC Pemetrexed Sales 2018-2023 (Units)
Figure 30. APAC Pemetrexed Revenue 2018-2023 ($ Millions)
Figure 31. Europe Pemetrexed Sales 2018-2023 (Units)
Figure 32. Europe Pemetrexed Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Pemetrexed Sales 2018-2023 (Units)
Figure 34. Middle East & Africa Pemetrexed Revenue 2018-2023 ($ Millions)
Figure 35. Americas Pemetrexed Sales Market Share by Country in 2022
Figure 36. Americas Pemetrexed Revenue Market Share by Country in 2022
Figure 37. Americas Pemetrexed Sales Market Share by Type (2018-2023)
Figure 38. Americas Pemetrexed Sales Market Share by Application (2018-2023)
Figure 39. United States Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Pemetrexed Sales Market Share by Region in 2022
Figure 44. APAC Pemetrexed Revenue Market Share by Regions in 2022
Figure 45. APAC Pemetrexed Sales Market Share by Type (2018-2023)
Figure 46. APAC Pemetrexed Sales Market Share by Application (2018-2023)
Figure 47. China Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Pemetrexed Sales Market Share by Country in 2022
Figure 55. Europe Pemetrexed Revenue Market Share by Country in 2022
Figure 56. Europe Pemetrexed Sales Market Share by Type (2018-2023)
Figure 57. Europe Pemetrexed Sales Market Share by Application (2018-2023)
Figure 58. Germany Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Pemetrexed Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Pemetrexed Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Pemetrexed Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Pemetrexed Sales Market Share by Application (2018-2023)
Figure 67. Egypt Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Pemetrexed Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Pemetrexed in 2022
Figure 73. Manufacturing Process Analysis of Pemetrexed
Figure 74. Industry Chain Structure of Pemetrexed
Figure 75. Channels of Distribution
Figure 76. Global Pemetrexed Sales Market Forecast by Region (2024-2029)
Figure 77. Global Pemetrexed Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Pemetrexed Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Pemetrexed Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Pemetrexed Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Pemetrexed Revenue Market Share Forecast by Application (2024-2029)
